# The Effect of Autonomic Neuropathy Status on the Endpoint Events in Diabetes Patients With Coronary Heart Disease and Sleep Apnea.

> **NCT07723222** · — · NOT_YET_RECRUITING · sponsor: **Xiangtan Central Hospital** · enrollment: 326 (estimated)

## Conditions studied

- Coronary Heart Disease
- Diabetes
- Sleep Apnea Syndrome
- Cardiovascular Autonomic Neuropathy (CAN)

## Interventions

- **BEHAVIORAL:** The total score of Ewing test (i.e. cardiovascular autonomic reflex test and heart rate variability) was ≥1, which was divided into cardiac autonomic neuropathy group (CAN grou

## Key facts

- **NCT ID:** NCT07723222
- **Lead sponsor:** Xiangtan Central Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2028-08-01
- **Final completion:** 2031-08-01
- **Target enrollment:** 326 (ESTIMATED)
- **Last updated:** 2026-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07723222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07723222, "The Effect of Autonomic Neuropathy Status on the Endpoint Events in Diabetes Patients With Coronary Heart Disease and Sleep Apnea.". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07723222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*